Balogun and the medical shock: Did Everton dodge a bullet or miss an opportunity?

The summer transfer window always has moments that make fans hold their breath, but few stories end as dramatically and ambiguously as Folarin Balogun's move to Everton. On the final day of the transfer window, everything seemed complete: the 25-year-old American was at Everton's training ground, ready to sign a deal worth £40 million ($54 million). But then, in a turn that surprised even the most seasoned scouts, the deal collapsed. The reason? The medical examination was not passed. The question is not just why the deal failed, but also: did Everton just dodge a financial bomb, or did they just miss a rare opportunity to solve their striking problem? The context of this deal is not simple. Everton, a club struggling with financial constraints under the Profit and Sustainability Rules (PSR), was ready to spend a significant amount to bring in a goalscoring striker. Balogun, with 13 goals in 30 Ligue 1 matches last season for Monaco, plus 3 goals at the 2026 World Cup as the top scorer for the US national team, seemed like the perfect fit. But what exactly happened in the medical room? Was it a recurring muscle injury, or a cardiovascular issue detected by Everton's medical staff? The truth is we don't know, and the fact that Everton — a club known for being cautious with every pound — was willing to spend £40 million and then immediately withdrew suggests the issue was not minor. Looking at the bigger picture, this deal exposes a harsh reality of the modern transfer market: a player's value lies not only in goals or skills on the pitch, but also in physical readiness. Balogun, despite clear potential, will now face the 'failed a medical' label — a stigma that could follow him throughout his career. For Monaco, they retain an asset that is gradually depreciating as his contract has only two years left. As for Everton, the need for a goalscoring striker remains open, and pressure from fans will only grow if the team starts the season poorly. But the story doesn't stop there. What makes this deal particularly special — and perhaps with the longest-lasting consequences — is the controversial intervention of former US President Donald Trump in the process of handling Balogun's suspension at the World Cup. A head of state publicly intervening in a FIFA disciplinary decision is unprecedented, and it has led to a formal complaint to FIFA's ethics committee. Is this a blatant political intervention aimed at serving domestic interests, given that the US is co-hosting the 2026 World Cup? And will FIFA be strong enough to handle this matter transparently, or will it quietly ignore it as a politically sensitive case? In that context, Balogun being allowed to play in the round of 16 (the 1-4 loss to Belgium) after his suspension was deferred, directly affected the US team's competitive outcome. This raises a big question about the integrity of the tournament: can the US team's results still be considered pure sporting achievements, or have they been 'tainted' by political intervention? This is a potential stain not only for FIFA but also for American football. Returning to Balogun, his career journey — from Arsenal's academy, through Middlesbrough, Reims, and then Monaco — shows a player who always knows how to find development opportunities. But failing a medical at age 25, the so-called peak phase, is a worrying signal. Is this a sign of a chronic physical issue that will follow him throughout his career? Or just a temporary setback? The answer will determine his future at Monaco and his ability to attract interest from other top clubs. On Everton's side, the absence of any official statement from the club after the deal collapsed only adds to the ambiguity. This could indicate they are trying to control the narrative, avoiding confirmation of Balogun's medical issues (which could be disputed), or simply avoiding embarrassment after a high-profile failure. Whatever the reason, this silence cannot hide a fact: Everton still desperately needs a striker, and time is running out. There is another, counter-intuitive perspective: the collapse of this deal could be a blessing in disguise for Everton. With £40 million, they were ready to spend on a player with a moderately good scoring record (13 goals/30 matches in Ligue 1), and failing the medical might have saved them from a financially unwise contract. In the context of tightening PSR, spending a large sum on a player with an injury history is a high-risk gamble. Perhaps this is an opportunity for Everton to reassess their recruitment strategy and look for safer, more sustainable options. However, the story of Trump's intervention remains a stubborn stain. It sets a dangerous precedent: if a head of state can intervene in FIFA's disciplinary decisions, other countries could follow suit. This erodes trust in the fairness and independence of the world football governing body. Will FIFA have the courage to handle this matter strictly, or will it choose silence to avoid confronting a political superpower? The answer will shape the future of global football governance. Ultimately, the Balogun-Everton deal is a story about the fragility of the transfer market, where a medical result can change everything. It is also a reminder that in modern football, not only talent and tactics matter, but also off-pitch factors — from finance to politics — can shape the fate of a player and a club. And when everything collapses, the biggest question remains: what have we learned from it?